NORCROSS, Ga. -- Regent Medical Americas, the North American arm of Regent Medical Ltd., announces completion of Regent Medical Ltds merger with Mölnlycke Health Care and Medlock Medical, creating a leading medical products group, Mölnlycke Health Care Group, with a strong brand focus.Â
According to Lundy Fields, formerly Regent Medical Americas president and now Mölnlycke Health Care U.S. president, the merger of Gothenburg, Sweden-based Mölnlycke Health Care with two Manchester, United Kingdom-based companies (Regent Medical and Medlock Medical), results in a new force in global healthcare. The compelling strategic fit between Mölnlycke and Regent, a leading surgical supplier known for its two brands Biogel® powder-free surgical gloves and HIBICLENS® antiseptic/antimicrobial skin cleanser, and Medlock, a niche wound care company, creates a company with a significantly enhanced product range and opportunity in the market, Fields said.
The companys two strategic divisions will be Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division will encompass a leading manufacturer and supplier of powder-free surgical gloves (Biogel® surgical gloves) and a leading supplier of skin cleanser (Hibiclens® and Hibistat® antiseptics). A leader in trauma and pain management, the Wound Care Divisions market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.Â
There are clear synergies between the companies in terms of sales force and distribution as well as in R&D; this, together with a more decentralized approach by management, will see the opportunities for cost savings, increased profitability and an accelerated top line growth.
Commenting on the new strategy, Mölnlycke CEO John Samuel said, The platform for future growth is in place and now it is time for us to focus on improving and expanding our business. Our strategy is two-fold: In Surgical, we plan to take advantage of the growing market need for single use products and further expand geographically; and in Wound Care, we plan to grow the advanced wound care business from the strong base of the market leading Safetac® technology both with innovative new products and further geographical spread.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.